Peripheral T cell lymphoma (PTCL) is a type of high grade (quickly growing) non Hodgkin lymphoma (NHL) that affects blood cells called T cells.
Doctors often use chemotherapy to treat PTCL. But sometimes it continues to grow, or comes back after the treatment has finished. So doctors are looking for new ways to treat people in this situation.
This trial is looking at 2 drugs called romidepsin and carfilzomib. The researchers want to see if romidepsin and carfilzomib help people who have already had other treatment for PTCL.
Please note that the trials team cannot give individual’s clinical advice. Patients and their families should contact their treating physician to discuss trials for which they may be eligible
| Chief Investigator: |
Dr Graham Collins |
| Sponsor: |
University of Birmingham |
| Funders: |
TAP Bloodwise |
| Disease Site: |
Peripheral T cell lymphoma |
| Trial Type: |
Clinical Trial of an Investigational Medicinal Product |
| Status: |
Open |
| UKCRN Study ID: (if applicable) |
15553 |
| Open to new sites? |
Yes |
| Recruitment start date: |
13-Jul-2015 |
| Anticipated Recruitment end date |
12-Jul-2018 |
| CRCTU Trial Management Team: |
Haematology Team |
| Trial E-mail Address: |
RomiCar@trials.bham.ac.uk |